Sterility testing is separate: chromatographic purity, mass spectrometry, and endotoxin testing all say nothing about whether a solution is sterile. If sterility matters, it needs to be tested and reported.
A certificate with no method stated: what can you conclude? posts 31–58
This is a continuation of a long topic, addressed by post number rather than by page. Start at post 1 · go to the accepted answer.
Endotoxin testing is separate: a certificate of purity says nothing about endotoxin. A chemically pure preparation can carry a clinically significant endotoxin load. If endotoxin matters, it needs to be tested and reported.
On post #30 — agreed on the reasoning, with one qualification.
Counter-ion form is crucial: peptides are isolated as salts, most often trifluoroacetate from reversed-phase purification or acetate after salt exchange. The counter-ion is part of the mass in the vial and is not part of the peptide. Two vials of the same purity, one as TFA and one as acetate, contain different amounts of peptide per milligram.
This follows post #32 rather than contradicting it.
Water content (residual moisture) matters: lyophilised peptide is not dry. A few percent water is normal. The difference between a TFA salt and an acetate salt can be several percent. Content calculations need the water content to be accurate.
What fields matter on a certificate: lot number matching the vial, test date, the analytical method stated specifically, the measured result as a number, and the acceptance limit stated separately. A certificate missing any of these is weaker.
Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing.
The correction was fair and I had been repeating something I had not checked carefully enough.
When method identifiers are missing: "reversed-phase HPLC" is less specific than "reversed-phase HPLC at 214 nm on a C18 column with a 10 to 40% acetonitrile gradient over 20 minutes". The second lets someone reproduce the analysis. The first does not.
Coming back to post #38, because the follow-up matters more than the original answer.
Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own records is not any individual result; it is that they are dated and consecutive.
A certificate of analysis is a statement by its issuer that a defined test was performed on a defined lot and produced a defined result. That is all it is, and it is not nothing. What makes it usable: lot identifier matching the container, test date, method identification specific enough to reproduce, the actual result as a number, and the acceptance criterion stated separately from the result.
When a document puts the specification in the result column, it has told you the release criterion, not the measurement. Those are different claims and the second is weaker.
Coming back to post #43, because the follow-up matters more than the original answer.
Reading old certificates: if a certificate is dated years ago, the lot it describes might be old. That is not automatically a problem but it is worth noting. Fresh testing on the current lot is stronger than old testing on an older lot.
Picking up post #43: that is the part I would want checked first.
When method identifiers are missing: "reversed-phase HPLC" is less specific than "reversed-phase HPLC at 214 nm on a C18 column with a 10 to 40% acetonitrile gradient over 20 minutes". The second lets someone reproduce the analysis. The first does not.
Sterility testing is separate: chromatographic purity, mass spectrometry, and endotoxin testing all say nothing about whether a solution is sterile. If sterility matters, it needs to be tested and reported.
What fields matter on a certificate: lot number matching the vial, test date, the analytical method stated specifically, the measured result as a number, and the acceptance limit stated separately. A certificate missing any of these is weaker.
I read post #47 twice before replying, because I had assumed the opposite.
A certificate of analysis is a statement by its issuer that a defined test was performed on a defined lot and produced a defined result. That is all it is, and it is not nothing. What makes it usable: lot identifier matching the container, test date, method identification specific enough to reproduce, the actual result as a number, and the acceptance criterion stated separately from the result.
Purity and content are different measurements: purity tells you what proportion of the detected material is the intended species. Content tells you how much of the intended species is present in the container. A lyophilised vial can be 99% pure and contain considerably less than the label claims because the remainder is water, counter-ion and excipient.
On post #48 — agreed on the reasoning, with one qualification.
Water content (residual moisture) matters: lyophilised peptide is not dry. A few percent water is normal. The difference between a TFA salt and an acetate salt can be several percent. Content calculations need the water content to be accurate.
Post hidden by community flags
Staff rationale: Hidden by community flags. The claim about a named supplier was not accompanied by a batch, a date, a method or a document, which R6 requires.
Counter-ion form is crucial: peptides are isolated as salts, most often trifluoroacetate from reversed-phase purification or acetate after salt exchange. The counter-ion is part of the mass in the vial and is not part of the peptide. Two vials of the same purity, one as TFA and one as acetate, contain different amounts of peptide per milligram.
The corresponding entry is in the public moderation log. Hidden posts are never deleted.
post #54 is right about the mechanism and I think understates the practical bit.
Endotoxin testing is separate: a certificate of purity says nothing about endotoxin. A chemically pure preparation can carry a clinically significant endotoxin load. If endotoxin matters, it needs to be tested and reported.
Worth separating two things that post #52 runs together.
Two things before anyone answers the substance.
First, the context in the first post is clear and specific. Second, the question is framed so that an answer can actually address it. Both are the norm here and both matter more than they sound.
Endotoxin testing is separate: a certificate of purity says nothing about endotoxin. A chemically pure preparation can carry a clinically significant endotoxin load. If endotoxin matters, it needs to be tested and reported.
Amino acid analysis gives content: it hydrolyses the peptide and quantifies the residues. It measures the peptide content independent of chromatographic purity. Very few supplier certificates report it.
Suggested topics
| Topic | Participants | Replies | Views | Activity |
|---|---|---|---|---|
|
A field-by-field walk through a certificate of analysis
Posting this under the heading it deserves: A field-by-field walk through a certificate of analysis Everything below is what sits behind that. A documentation question rather than an analytical one. I have a…
|
+136 | 147 | 1.8k | 12mo |
|
A checklist for reading a certificate in under two minutes — does this still hold?
A checklist for reading a certificate in under two minutes — does this still hold? — that is the question, and I have not found it answered plainly anywhere I have looked. I would like to understand what this…
|
+49 | 55 | 15k | 9mo |
|
What a certificate commits its issuer to — the long version
Asking directly, because I could not find a straight answer: What a certificate commits its issuer to — the long version A documentation question rather than an analytical one. I have a certificate in front…
|
+20 | 26 | 21k | 2d |
|
Second pass at: A field-by-field walk through a certificate of analysis
Second pass at: A field-by-field walk through a certificate of analysis Writing it up because I had to work it out twice and would rather nobody else did. A documentation question rather than an analytical…
|
+149 | 164 | 36k | 19mo |
|
Counter-ion form: the field almost nobody reports — one year on
On the subject in the title: Counter-ion form: the field almost nobody reports — one year on Working notes rather than a conclusion. A documentation question rather than an analytical one. I have a…
|
+121 | 139 | 31k | 16mo |
Related topics — sharing the tags certificate of analysis, batch & lot numbers, documentation quality
| Topic | Participants | Replies | Views | Activity |
|---|---|---|---|---|
|
Reconciling a label claim with a content assay
On the subject in the title: Reconciling a label claim with a content assay Working notes rather than a conclusion. I would like to understand what this number means before I repeat it anywhere. A…
|
+2 | 6 | 183 | 4mo |
|
One lot is one lot: when a report becomes a pattern — the long version
One lot is one lot: when a report becomes a pattern — the long version — setting out what I have, and where I think it stops being reliable. Structured report rather than an opinion, following the format the…
|
+137 | 152 | 46k | 16mo |
|
Comparing documentation quality across the directory, tabulated
Comparing documentation quality across the directory, tabulated — setting out what I have, and where I think it stops being reliable. I would like to talk about documentation quality as a signal, separately…
|
+7 | 11 | 29k | 19h |
|
Batch numbers that do not match the vial label — what changed since
On the subject in the title: Batch numbers that do not match the vial label — what changed since Working notes rather than a conclusion. A logistics question, since the answers here are usually better than…
|
+39 | 43 | 14k | 1mo |
|
Coming back to: Why our vendor pages link the storefront and mark it sponsored
Why our vendor pages link the storefront and mark it sponsored I have a specific reason for asking rather than idle curiosity, and the context is below. Structured report rather than an opinion, following the…
|
2 | 22k | 8h |